Stockreport

Pulmonx Reports Third Quarter 2025 Financial Results [Yahoo! Finance]

Pulmonx Corporation  (LUNG) 
US:NASDAQ Investor Relations: investor.prolunginc.com/investor-relations
PDF the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the third quarter of 2025 ended September 30, 202 [Read more]